UCB - Passività Correnti





Passività Correnti Cambiamento Data
Alcon AG USD 3B 45M 2026-03
Almirall EUR 323.65M 26.99M 2026-06
Amarin USD 164.2M 15.45M 2026-06
argenx SE USD 1.58B 254.81M 2026-06
AstraZeneca USD 31.55B 1.02B 2026-06
Bayer EUR 32.27B 1.19B 2026-06
Genmab DKK 1.14B 38M 2026-06
GlaxoSmithKline GBP 21.53B 895M 2026-06
GRIFOLS EUR 2.24B 112M 2026-06
Hikma Pharmaceutical USD 1.45B 603M 2025-12
Lakefront Biotherapeutics EUR 70.32M 30.1M 2026-06
Lonza CHF 3.57B 421M 2025-12
Merck EUR 8.12B 1.22B 2026-06
Novartis USD 31.75B 374M 2026-06
Orion EUR 454.5M 344.1M 2026-06
Recordati EUR 1.4B 30.88M 2026-06
Roche Holding CHF 28.85B 846M 2026-06
Sanofi EUR 31.93B 1.92B 2026-06
UCB EUR 4.4B 470M 2025-12
Unibail Rodamco EUR 3.13B 2.32B 2025-12